Market Cap 751.46M
Revenue (ttm) 87.37M
Net Income (ttm) -301.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -345.36%
Debt to Equity Ratio 0.00
Volume 1,321,100
Avg Vol 1,564,250
Day's Range N/A - N/A
Shares Out 89.14M
Stochastic %K 89%
Beta -0.49
Analysts Strong Sell
Price Target $11.62

Company Profile

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. Its lead products candidate includes avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fix...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 682 0917
Website: amylyx.com
Address:
43 Thorndike Street, Cambridge, United States
ajmore
ajmore Jul. 17 at 1:59 PM
$AMLX 8 usd price hardly reflects the discounted cash flow from wolfram drug!. Avexitide discounted cash flow >7 bln!.
1 · Reply
PulseFutures
PulseFutures Jul. 16 at 6:28 PM
Getting closer! $AMLX
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 16 at 2:30 PM
$VVPR Good Morning ☕️ $MIRA $NEWH $RXRX $AMLX
0 · Reply
ajmore
ajmore Jul. 15 at 2:48 PM
$AMLX love the posters. expected after yesterday' action especially that we got some shorts still try to avg up their short price.... like hello! now heres the deal plot the 2 year chart and see what happened from this level!. yep, climb up to 34!.
1 · Reply
Doozio
Doozio Jul. 14 at 10:14 PM
$AMLX pretty soon they gonna $BRAG 🐒🍌🧠⏰♾️
1 · Reply
I_AM_GHEY
I_AM_GHEY Jul. 14 at 5:27 PM
$AMLX $10 by EOY
1 · Reply
TeeMan123
TeeMan123 Jul. 14 at 4:55 PM
$AMLX interestingly on a non-deal roadshow with Jefferies, a firm that doesn’t currently cover them. It would be great to see an initiation post-roadshow by this research firm, ideally before the PSP interim readout, would boost visibility ahead of a key catalyst.
0 · Reply
PharmaFrank
PharmaFrank Jul. 14 at 2:47 PM
$AMLX What’s going on? I thought we had good news?
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 14 at 12:45 PM
$RXRX Good Morning ☕️ $VVPR $XRP.X $MSTY $AMLX
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 14 at 12:37 PM
$AMLX (+6.0% pre) Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025 https://ooc.bz/l/69822
0 · Reply
Latest News on AMLX
Amylyx Drug Slashes Sugar Spikes Post-Weight Loss Surgery

Jul 14, 2025, 2:15 PM EDT - 3 days ago

Amylyx Drug Slashes Sugar Spikes Post-Weight Loss Surgery


Amylyx Eyes $2B Opportunity In Post-Surgery Sugar Crash Market

Jun 24, 2025, 2:59 PM EDT - 23 days ago

Amylyx Eyes $2B Opportunity In Post-Surgery Sugar Crash Market


ajmore
ajmore Jul. 17 at 1:59 PM
$AMLX 8 usd price hardly reflects the discounted cash flow from wolfram drug!. Avexitide discounted cash flow >7 bln!.
1 · Reply
PulseFutures
PulseFutures Jul. 16 at 6:28 PM
Getting closer! $AMLX
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 16 at 2:30 PM
$VVPR Good Morning ☕️ $MIRA $NEWH $RXRX $AMLX
0 · Reply
ajmore
ajmore Jul. 15 at 2:48 PM
$AMLX love the posters. expected after yesterday' action especially that we got some shorts still try to avg up their short price.... like hello! now heres the deal plot the 2 year chart and see what happened from this level!. yep, climb up to 34!.
1 · Reply
Doozio
Doozio Jul. 14 at 10:14 PM
$AMLX pretty soon they gonna $BRAG 🐒🍌🧠⏰♾️
1 · Reply
I_AM_GHEY
I_AM_GHEY Jul. 14 at 5:27 PM
$AMLX $10 by EOY
1 · Reply
TeeMan123
TeeMan123 Jul. 14 at 4:55 PM
$AMLX interestingly on a non-deal roadshow with Jefferies, a firm that doesn’t currently cover them. It would be great to see an initiation post-roadshow by this research firm, ideally before the PSP interim readout, would boost visibility ahead of a key catalyst.
0 · Reply
PharmaFrank
PharmaFrank Jul. 14 at 2:47 PM
$AMLX What’s going on? I thought we had good news?
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 14 at 12:45 PM
$RXRX Good Morning ☕️ $VVPR $XRP.X $MSTY $AMLX
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 14 at 12:37 PM
$AMLX (+6.0% pre) Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025 https://ooc.bz/l/69822
0 · Reply
ajmore
ajmore Jul. 14 at 10:41 AM
$AMLX Wainwright reiterates Buy with target 16.
0 · Reply
G101SPM
G101SPM Jul. 14 at 9:49 AM
$AMLX $8.05 bid. DAC (dollar average cost) $1.8 (8.12.24). EXIT $15.00. BRIEF: Today announced the presentation of new exploratory analyses from the Phase 2 PREVENT and Phase 2b clinical trials of avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist for the treatment of post-bariatric hypoglycemia (PBH) at the Endocrine Society’s annual meeting (ENDO 2025).
0 · Reply
ajmore
ajmore Jul. 14 at 8:08 AM
$AMLX Expecting target prices raised. towards the 20 usd mark. Analysts see 3 bln revenue potential and at 20 usd target thats not even taking account of 1bl revenue.
0 · Reply
ajmore
ajmore Jul. 14 at 8:02 AM
$AMLX Top notch data!
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 14 at 3:04 AM
Amylyx Pharma Gains Retail Buzz As Once-Daily Pill Cuts Severe Blood Sugar Crashes In Mid-Stage Trial $AMLX https://stocktwits.com/news/equity/markets/amylyx-pharma-gains-retail-buzz-as-once-daily-pill-cuts-severe-blood-sugar-crashes-in-mid-stage-trial/ch8BjflR5NA
0 · Reply
AlertsAndNews
AlertsAndNews Jul. 13 at 10:44 PM
$AMLX Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025 Amylyx posts 64% reduction in severe hypoglycemic events with avexitide 90mg daily in Ph2b. Phase 3 LUCIDITY trial ongoing in post-bariatric hypoglycemia; topline data expected 1H 2026. 24-hour therapeutic exposure confirmed. Investor event tonight at 9PM ET.
0 · Reply
LosersMakeMillions
LosersMakeMillions Jul. 13 at 9:15 PM
$AMLX Amylyx to host an in-person and virtual investor event today, July 13, 2025, at 6:00 p.m. PT / 9:00 p.m. ET
0 · Reply
LosersMakeMillions
LosersMakeMillions Jul. 13 at 9:12 PM
$AMLX https://www.amylyx.com/news/amylyx-pharmaceuticals-presents-new-exploratory-analyses-from-phase-2-and-phase-2b-clinical-trials-of-avexitide-in-post-bariatric-hypoglycemia-at-endo-2025
0 · Reply
themacromindset
themacromindset Jul. 13 at 9:10 PM
$AMLX - Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025
0 · Reply
WOLFSTREET
WOLFSTREET Jul. 11 at 8:08 PM
Story: Had a friend call me telling me how much she hates lines and how deceptive and subjective they are, people look at picture-books and then run off and draw lines that get them all excited. I said OH yeah, I agree!! So she asked me for list access, I said, well, this is a good beta test opp and I said YES, we agreed she would not share and would pick 9 (3/relevant-list) to go buy at market this AM at the OPEN. I think she was doing about $500 per play to test drive CC. As part of agreement, she had to tell me which ones. She picked $STNE and I was impressed. Also some others I have already shared. $AMLX was another, I'll need to cover that one for my friends here. I expect her input to help me better understand the mind when taking CC for a 1st lap around the track.
0 · Reply
djgestates
djgestates Jul. 11 at 11:30 AM
0 · Reply